Overview
Douglas Micalizzi is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Micalizzi is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. His top areas of expertise are HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, and Hypothalamic Hamartomas. Dr. Micalizzi is currently accepting new patients.
His clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
40 2nd Ave, Waltham, MA 02451
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Nadine Tung is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as an Elite provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Breast Cancer, Ovarian Cancer, HER-2 Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Judy Garber is a Hematologist Oncology specialist and an Oncologist in South Weymouth, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, and Tieche-Jadassohn Nevus. Dr. Garber is currently accepting new patients.
Lahey Clinic Inc
Lata Thatai is a Hematologist Oncology specialist and a Hematologist in Burlington, Massachusetts. Dr. Thatai is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, Liver Embolization, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- BRCA Positive Breast CancerDr. Micalizzi isDistinguished. Learn about BRCA Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Micalizzi isDistinguished. Learn about HER2 Negative Breast Cancer.
- Li-Fraumeni SyndromeDr. Micalizzi isDistinguished. Learn about Li-Fraumeni Syndrome.
- Experienced
- Anal CancerDr. Micalizzi isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Micalizzi isExperienced. Learn about Angiosarcoma.
- Breast CancerDr. Micalizzi isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Micalizzi isExperienced. Learn about Breast Cancer in Men.
- Cowden SyndromeDr. Micalizzi isExperienced. Learn about Cowden Syndrome.
- Hypothalamic HamartomasDr. Micalizzi isExperienced. Learn about Hypothalamic Hamartomas.